news
Durham Study Finds Psychedelic Mental Health Benefits Fade With Age
A Durham University study of over 1,000 adults found classic psychedelics like psilocybin and LSD correlate with lower anxiety and depression in younger adults, but the link vanishes completely as participants get older. The data suggests that recreational or therapeutic psychedelic use does not automatically deliver the same mood lift to older nervous systems.
A Durham University study of over 1,000 adults found classic psychedelics like psilocybin and LSD correlate with lower anxiety and depression in younger adults, but the link vanishes completely as participants get older. The data suggests that recreational or therapeutic psychedelic use does not automatically deliver the same mood lift to older nervous systems.
The architecture take
I used to assume psilocybin was an equal-opportunity reset button for any fried brain. I've watched friends in their twenties take one dose and reorder their emotional baseline for months. This Durham survey of 1,000 adults punctured that fantasy. Classic psychedelics bind to 5-HT2A serotonin receptors to spark neuroplasticity, temporarily shaking up stubborn thought loops. Younger brains still have enough baseline malleability to convert that chemical jolt into lower anxiety. By your late forties, receptor density drops and neural pathways settle like dry clay. An unguided trip simply doesn't move the needle on depression anymore. I suspect the venture-backed clinic circuit will quietly bury this paper, because selling five-thousand-dollar macro-dose packages to burnt-out fifty-somethings is where the margins live. Biology is stubborn. If you're expecting a fungus to do your emotional lifting after forty, you'll be disappointed.